BioSpace News Archive

AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced that Hamza Suria, chief executive officer of AnaptysBio, will present at the 2020 Cantor Global Virtual Healthcare Conference on Thursday, September 17, 2020 at 12:00 p.m. ET

Amgen (NASDAQ:AMGN) will present at Morgan Stanley’s 18th Annual Virtual Global Healthcare Conference at 11:45 a.m. ET on Wednesday, Sept. 16, 2020.

Formerly of Wellstar and Sutter Health, Owen Plietz brings decades of health system experience to Kaiser Permanente

SmileDirectClub, Inc., the oral care company with the first medtech platform for teeth straightening, announced that management will attend the Morgan Stanley 18th Annual Global Healthcare Conference on Thursday, September 17th, with a Fireside Chat that same day at 1:15 PM ET.

Guardion Health Sciences, Inc. announced that due to the public health concerns related to COVID-19 and to support the health and safety of its stockholders, employees and communities, it will provide virtual attendance at its 2020 Annual Meeting of Stockholders.

The bill from Rep. Robin Kelly (D-IL) extends protections to low-income and minority communities during COVID-19

Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announces that it has filed its annual financial statements for the year ended April 30, 2020, related MD&A and annual information form pursuant to National Instrument 51-102 (collectively, the “Annual Filings”).

A blood test that can identify a variety of mutations in advanced breast cancer can reliably match women to effective targeted treatments, early results of a major clinical trial reveal.

Ascendis Pharma A/S, a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, announced that the company will participate in the 18th Annual Morgan Stanley Virtual Global Healthcare Conference in September.

Bruker Corporation announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy.